The advantage of anti-rat thymocyte globulin treated newborn Wistar rats over the nude mouse system in revealing the metastatic potential of continuous cell lines was demonstrated previously. We were able to significantly in""""""""crease the sensitivity of the rat system for low or moderately malignant continuous cell lines by using the intraperitoneal route for inoculation of cells and by increasing the number of cells per inoculum. An abstract will be published in August 1990 and a poster presentation is accepted by the 15th International Cancer Congress.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BE003007-01
Application #
3811237
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost